Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIIb Study of Recombinant Tetravalent HPV Vaccine in Patients With Recurrent Respiratory Papillomatosis

NCT01375868 is registered in ClinicalTrials.gov with Ruth Tachezy, PhD. as lead sponsor.

NCT NCT01375868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01375868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIIb Study of Recombinant Tetravalent HPV Vaccine in Patients With Recurrent Respiratory Papillomatosis
Lead sponsor
Ruth Tachezy, PhD.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2011
Completion date
December 31, 2018
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

squamous papilloma of the larynx